Drug companies will move away from sectors subject to price controls, former FDA chief Scott Gottlieb

Former FDA commissioner Dr. Scott Gottlieb joins CNBC ‘Power Lunch’ to discuss investing in pharmaceuticals, the Covid pandemic, and J&J’s $8.9 billion talc product settlement.